PHARMACEUTICALS AND PHYSICAL THERAPY: MOVEMENT WITH MEDICATION Final Examination Questions Select the best answer for each question and mark your answers on the Final Examination Answer Sheet found on page 222, or complete your test online at EliteLearning.com/Book
1. Therapeutic window refers to the relationship between: a. Time of dose administration versus time of peak effect. b. Route of dose administration versus site of physiologic effect. c. Minimum therapeutic dose versus minimum toxic dose. d. Maximum therapeutic dose versus maximum toxic dose. 2. Volume of distribution for a given pharmaceutical: a. May exceed physical volume in the body. b. Never reaches full physical volume in the body. c. Is completely independent of physical volume in the body. d. Is limited to intracellular physical volume in the body. 3. The purpose of delivering a loading dose of a given pharmaceutical is: a. Decrease the waiting period for immediate effects. b. Delay the period before drug elimination occurs. c. Introduce a new drug to the body for the first time. d. Decrease the time period required to reach a steady state. 4. For patients with comorbidities such as hypertension and chronic obstructive pulmonary disease, prescription of beta-blockers is often: a. Allowed, due to dual system pharmacologic therapeutic effects. b. Highly advocated, due to the dual system pharmacologic therapeutic effects. c. Contraindicated, due to increased potential for induced acute bronchial smooth muscle spasm. d. Allowed, due to minimal risk for adverse effects. 5. The primary therapeutic effect of nitrates on angina include: a. Increased venous capacitance and decreased ventricular preload.
6. Sublingual nitrate administration is associated with: a. Delayed therapeutic effects due to inefficient absorption. b. Reduced pharmacologic activity due to first pass metabolism. c. Prolonged pharmacologic activity due to administration route. d. Rapid pharmacologic action due to administration route. 7. Patients presenting with medical history significant for cardiac arrhythmia are often prescribed: a. Pharmaceuticals with individually categorized mechanisms of action. b. Beta-adrenoceptor-blocking drugs. c. Calcium-channel blocking drugs. d. Broad-spectrum antiarrhythmic pharmaceuticals. 8. The mechanism of action for corticosteroid drug therapy in the presence of asthma does not include: a. Reducing heart rate to limit blood supply to the lungs. b. Relaxing bronchial smooth muscle. c. Increasing mucosal production. d. Neuromuscular sedation. 9. Following general medical stability, what is the most important objective information for a physical therapist to obtain prior to progressing a patient in recovery status post elective total knee arthroplasty? a. Lower extremity somatic sensation. b. Subjective pain level. c. Lower extremity strength. d. Global rate of perceived exertion. 10. The pharmacodynamics effects of opioids are multi-
dimensional in terms of simultaneous: a. Somatosensation and emotion. b. Tachypnea and bradycardia. c. Pruritus and inflammation. d. Anticoagulation and vasodilation.
b. Increased platelet aggregation. c. Reduced coronary blood flow. d. Increased pain relief from a headache.
Course Code : PTGA04PM
EliteLearning.com/Physical-Therapy
Page 195
Powered by FlippingBook